Five medium-term triggers that can contribute to a 35% upside in Aurobindo Pharma shares

Nuvama said investments topping ₹10,000 crore in new assets have diluted Aurobindo Pharma’s returns ratios.

Nuvama said investments topping ₹10,000 crore in new assets have diluted Aurobindo Pharma’s returns ratios.

The Nifty rose 1.29% on Friday to close at 25,112, while the Sensex jumped 1,046 points to end at 82,408. Both the benchmark indices ended the week on a strong note, recovering losses from the previous week, as easing domestic concerns…

Harish Krishnan, Co-CIO and Head of Equity at Aditya Birla Sun Life AMC, expects stronger corporate earnings in the second half of the current fiscal year and remains constructive on equities over the next 2-3 years.

Kotak said that it would look for consistent earnings delivery versus already-high expectations before adopting a more constructive view on the Aether Industries stock.

HSBC has valued Vishal Mega Mart at 65x target price-to-earnings multiple, a 15% discount to Trent’s standalone business.

The number of shares that will be freeing up for trading amount to $17 billion in value, according to the latest note by Nuvama Alternative and Quantitative Research.

In March 2025, Dilip Buildcon’s joint venture had secured a contract from BSNL for Bharat Net Phase III project.

Drew Pettit, Director of US Equity Strategy and ETF Research at Citi, maintained a neutral stance on the US, noting that while underlying fundamentals remain strong, much of the positive outlook is already priced into valuations.

At the interbank foreign exchange, the rupee opened at 86.65 against the US dollar before rising to 86.60, up 13 paise from its previous close.

As highlighted by HSBC, Page Industries’ topline growth will moderate as all three segments are missing drivers, unlike the past when at least one of the segments achieved above-average growth.